These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28786142)

  • 21. Pravastatin therapy fails to suppress post-PCI inflammatory response measured by serum neopterin and CRP levels.
    Bozbaş H; Mermer S; Yıldırır A; Konaş D; Atar I; Aydınalp A; Ozin B; Korkmaz ME; Müderrisoğlu H
    Anadolu Kardiyol Derg; 2011 May; 11(3):207-12. PubMed ID: 21421511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
    Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
    J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preprocedural statin therapy to prevent myocardial damage in percutaneous coronary intervention: a review of randomized trials.
    Mega S; Patti G; Cannon CP; Di Sciascio G
    Crit Pathw Cardiol; 2010 Mar; 9(1):19-22. PubMed ID: 20215906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention.
    Liu Z; Joerg H; Hao H; Xu J; Hu S; Li B; Sang C; Xia J; Chu Y; Xu D
    Ann Pharmacother; 2016 Sep; 50(9):725-33. PubMed ID: 27307415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes.
    Marenzi G; Cosentino N; Werba JP; Tedesco CC; Veglia F; Bartorelli AL
    Int J Cardiol; 2015 Mar; 183():47-53. PubMed ID: 25662053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial.
    Berwanger O; Santucci EV; de Barros E Silva PGM; Jesuíno IA; Damiani LP; Barbosa LM; Santos RHN; Laranjeira LN; Egydio FM; Borges de Oliveira JA; Dall Orto FTC; Beraldo de Andrade P; Bienert IRC; Bosso CE; Mangione JA; Polanczyk CA; Sousa AGMR; Kalil RAK; Santos LM; Sposito AC; Rech RL; Sousa ACS; Baldissera F; Nascimento BR; Giraldez RRCV; Cavalcanti AB; Pereira SB; Mattos LA; Armaganijan LV; Guimarães HP; Sousa JEMR; Alexander JH; Granger CB; Lopes RD;
    JAMA; 2018 Apr; 319(13):1331-1340. PubMed ID: 29525821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin loading before percutaneous coronary intervention to reduce periprocedural myocardial infarction.
    Norris DM; Anderson JR
    Cardiol Rev; 2012; 20(6):319-24. PubMed ID: 22874885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.
    Di Sciascio G; Patti G; Pasceri V; Gaspardone A; Colonna G; Montinaro A
    J Am Coll Cardiol; 2009 Aug; 54(6):558-65. PubMed ID: 19643320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study.
    Nosaka K; Miyoshi T; Iwamoto M; Kajiya M; Okawa K; Tsukuda S; Yokohama F; Sogo M; Nishibe T; Matsuo N; Hirohata S; Ito H; Doi M
    Int J Cardiol; 2017 Feb; 228():173-179. PubMed ID: 27865182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous coronary interventions and statins therapy.
    Nusca A; Melfi R; Di Sciascio G
    Ther Adv Cardiovasc Dis; 2008 Apr; 2(2):101-7. PubMed ID: 19124413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome.
    Chang SM; Yazbek N; Lakkis NM
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):193-7. PubMed ID: 15170709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin pretreatment and presentation patterns in patients with coronary artery disease.
    Ndrepepa G; Fusaro M; King L; Cassese S; Tada T; Schömig A; Kastrati A
    Cardiol J; 2013; 20(1):52-8. PubMed ID: 23558811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of the role of high-dose statins administered prior to percutaneous coronary intervention in reducing major adverse cardiac events in patients with coronary artery disease.
    Hao PP; Chen YG; Wang JL; Ji WQ; Xue L; Liu XH; Wang XL; Zhang Y
    Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):496-500. PubMed ID: 19930422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina.
    Mostowik M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Gajos G
    Adv Clin Exp Med; 2015; 24(6):979-85. PubMed ID: 26771969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
    Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: a meta-analysis.
    Zhang F; Dong L; Ge J
    Ann Med; 2010 Apr; 42(3):171-7. PubMed ID: 20384433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of intensive statin use on the level of inflammation and platelet activation in stable angina after percutaneous coronary intervention: a clinical study.
    Li Q; Deng SB; Xia S; Du JL; She Q
    Med Clin (Barc); 2013 Jun; 140(12):532-6. PubMed ID: 23177313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preprocedural statin use in patients undergoing percutaneous coronary intervention.
    Kenaan M; Seth M; Aronow HD; Naoum J; Wunderly D; Mitchiner J; Moscucci M; Gurm HS;
    Am Heart J; 2014 Jul; 168(1):110-6.e3. PubMed ID: 24952867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Short-term clinical effects of periprocedural statin therapy].
    Ambrosi P
    Presse Med; 2013 Mar; 42(3):261-8. PubMed ID: 22884240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.